Endocrine Abstracts

Background and aims: To describe the characteristics of patients with non-controlled type 2 diabetes mellitus with liraglutide treatment.Materials and methods: Retrospective descriptive study. 85 outpatients (women 49, ages 18–86 years old with non-controlled type 2 diabetes mellitus were evaluated between July 2013 and March 2014 and received treatment with liraglutide 1.8 mg Q18/day (0.6 mg Q18 during the first week, 1.2 mg Q18 during the send wee...

Background and aims: To describe the characteristics of patients with non-controlled type 2 diabetes mellitus with liraglutide treatment.Materials and methods: Retrospective descriptive study. 85 outpatients (women 49, ages 18–86 years old with non-controlled type 2 diabetes mellitus) were evaluated between July 2013 and March 2014 and received treatment with liraglutide 1.8 mg SQ/day (0.6 mg SQ during the first week, 1.2 mg SQ during the second wee...

Hyperthyroidism during pregnancy is determined by decreased thyroid stimulating hormone (TSH), and high levels of thyroid hormones: thyroxine (T4), triiodothyronine (T3), being a complication in 1–2 women per 1,000 pregnancies, and occurs first as Graves’ disease in 0.1–1% of pregnancies. There are specific reference ranges of THS and free T4 for each population and each trimester. For the medical management in the first trimeste...

Introduction: Non-classic congenital adrenal hyperplasia (NCCAH) is an autosomal recessive disorder, that affects adrenal steroidogenesis, and it is characterized by an enzymatic defect in corticosteroids biosynthesis. NCCAH diagnosis is based on the determination of 17a-hydroxiprogesterone (17a-OHP) basal levels, and levels after stimulation with adrenocorticotropic hormone (ACTH), and it is confirmed with molecular testing. Treatment is still controversial, and it must be in...